According to a newly published market research report by 24LifeSciences, global PD-1 and PD-L1 monoclonal antibody market was valued at USD 32.6 billion in 2025 and is projected to reach USD 63.4 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.7% during the forecast period 2026–2034. PD-1/PD-L1 monoclonal antibodies represent a groundbreaking class of...